Crestone, Inc.

Boulder, CO 80301

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $5.62MM
First Award Date 07/06/10
Most Recent Award Date 09/01/16

Key Personnel

Last Name Name Awards Contact
Jarvis Thale Cross Jarvis 8
DEGROOTE MARY ANN DEGROOTE 3

8 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/01/16 - 08/31/17

? DESCRIPTION (provided by applicant): The nontuberculous Mycobacteria (NTM) are a growing public health concern as the number of opportunistic infections increases. Although not a reportable disease, there is growing epidemiologic evidence to suggest that NTM cause more infections today in the United States than Mycobacterium tuberculosis (M...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/15/15 - 09/14/16

DESCRIPTION (provided by applicant): The nontuberculous Mycobacteria (NTM) are a growing public health concern as the number of opportunistic infections increases. Although not a reportable disease, there is growing epidemiologic evidence to suggest that NTM cause more infections today in the United States than Mycobacterium tuberculosis (Mtb) y...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 08/01/14 - 01/31/15

DESCRIPTION (provided by applicant): The non-tuberculous mycobacteria (NTM) are a growing public health concern as the number of opportunistic infections increases. Although not a reportable disease, there is growing epidemiologic evidence to suggest that NTM cause more infections today in the United States than Mycobacterium tuberculosis (Mtb)...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 07/01/14 - 06/30/15

DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We are developing a novel class of small molecule antibiotics ("TZUs") targeting PolC, the replicative DNA polymerase in Gram-positive bacteria. These agents exhibit broa...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 07/01/13 - 06/30/14

DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We are developing a novel class of small molecule antibiotics ("TZUs") targeting PolC, the replicative DNA polymerase in Gram-positive bacteria. These agents exhibit broa...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 07/01/12 - 06/30/13

DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We are developing a novel class of small molecule antibiotics ("TZUs") targeting PolC, the replicative DNA polymerase in Gram-positive bacteria. These agents exhibit broa...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AI-09-029
Budget: 07/01/11 - 06/30/12

DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We have discovered and optimized a novel class of antibiotics targeting PolC, the replicative DNA polymerase in Gram-positive bacteria. These agents exhibit broad spectru...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AI-09-029
Budget: 07/06/10 - 06/30/11

DESCRIPTION (provided by applicant): The alarming increase in incidence of infections caused by drug-resistant bacteria has created an urgent need for new antibacterial agents. We have discovered and optimized a novel class of antibiotics targeting PolC, the replicative DNA polymerase in Gram-positive bacteria. These agents exhibit broad spectru...